Jazz Pharmaceuticals (JAZZ) Superinvestor holders
17 of the superinvestors we track hold Jazz Pharmaceuticals (JAZZ) in their latest 13F filings, $1.4B in total.
Summary
The largest holder is Josef Lakonishok (LSV Asset Management), with $495M, 0.9% of the portfolio.
In their latest quarter: 1 opened a new position, 6 added, 10 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| Josef Lakonishok LSV Asset Management |
Trimmed | 2,135,935 | $495M | 0.9% | Q3 2026 |
| Cliff Asness AQR Capital Management |
Added | 1,522,568 | $360M | 0.1% | Q2 2026 |
| Jim Simons Renaissance Technologies |
Trimmed | 562,073 | $135M | 0.2% | Q2 2026 |
| Two Sigma Two Sigma Investments |
Added | 400,212 | $96M | 0.1% | Q2 2026 |
| Bernard Horn Polaris Capital Management |
Trimmed | 320,466 | $74M | 7.8% | Q3 2026 |
| Aziz Hamzaogullari Loomis Sayles & Co |
Trimmed | 198,162 | $48M | 0.1% | Q2 2026 |
| Brandon Haley Holocene Advisors |
Trimmed | 160,991 | $39M | 0.1% | Q2 2026 |
| Man Group Man Group plc |
Added | 152,877 | $37M | 0.1% | Q2 2026 |
| Joel Greenblatt Gotham Asset Management |
Added | 112,014 | $27M | 0.1% | Q2 2026 |
| Howard Gleicher Aristotle Capital Management |
Trimmed | 111,697 | $27M | 0.1% | Q2 2026 |
| David Shaw D. E. Shaw & Co. |
Trimmed | 87,075 | $21M | 0.0% | Q2 2026 |
| Tweedy, Browne Tweedy, Browne Company |
Trimmed | 59,279 | $14M | 1.1% | Q3 2026 |
| Paul Marshall Marshall Wace |
Added | 34,793 | $8M | 0.0% | Q2 2026 |
| Ensign Peak Ensign Peak Advisors |
Added | 17,679 | $4M | 0.0% | Q2 2026 |
| Hotchkis & Wiley Hotchkis & Wiley Capital Management |
Trimmed | 13,133 | $3M | 0.0% | Q2 2026 |
| Dan Davidowitz Polen Capital Management |
New position | 1,858 | $447,722 | 0.0% | Q2 2026 |
| Acadian Acadian Asset Management |
Trimmed | 640 | $147,000 | 0.0% | Q3 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 17 |
| Q1 2026 | 19 |
| Q4 2025 | 20 |
| Q3 2025 | 16 |
| Q2 2025 | 17 |
| Q1 2025 | 21 |
| Q4 2024 | 17 |
| Q3 2024 | 18 |
Questions about Jazz Pharmaceuticals
Which superinvestors own Jazz Pharmaceuticals?
17 of the superinvestors we track hold Jazz Pharmaceuticals (JAZZ) in their latest 13F filings, $1.4B in total. Josef Lakonishok, Cliff Asness, Jim Simons, Two Sigma, Bernard Horn, Aziz Hamzaogullari.
Who is the largest superinvestor holder of JAZZ?
The largest holder is Josef Lakonishok (LSV Asset Management), with $495M, 0.9% of the portfolio.
From Jazz Pharmaceuticals's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.